{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T18:10:19Z","timestamp":1794507019388,"version":"4.9.1"},"reference-count":12,"publisher":"American Medical Association (AMA)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Ophthalmol"],"published-print":{"date-parts":[[2019,1,1]]},"DOI":"10.1001\/jamaophthalmol.2018.5191","type":"journal-article","created":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T11:52:17Z","timestamp":1541073137000},"page":"96","source":"Crossref","is-referenced-by-count":25,"title":["Association of Cancer Immunotherapy With Acute Macular Neuroretinopathy and Diffuse Retinal Venulitis"],"prefix":"10.1001","volume":"137","author":[{"given":"Leisha A.","family":"Emens","sequence":"first","affiliation":[{"name":"Bloomberg-Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University School of Medicine, Baltimore, Maryland"},{"name":"now with University of Pittsburgh Medical Center Hillman Cancer Center, Pittsburgh, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. Lindsey","family":"Davis","sequence":"additional","affiliation":[{"name":"University of Colorado Cancer Center, Aurora"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott C. N.","family":"Oliver","sequence":"additional","affiliation":[{"name":"University of Colorado Eye Center, University of Colorado School of Medicine, Aurora"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher H.","family":"Lieu","sequence":"additional","affiliation":[{"name":"University of Colorado Cancer Center, Aurora"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashvini","family":"Reddy","sequence":"additional","affiliation":[{"name":"Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon","family":"Solomon","sequence":"additional","affiliation":[{"name":"Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingmin","family":"He","sequence":"additional","affiliation":[{"name":"Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland","family":"Morley","sequence":"additional","affiliation":[{"name":"Genentech Inc, South San Francisco, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcella","family":"Fass\u00f2","sequence":"additional","affiliation":[{"name":"Genentech Inc, South San Francisco, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Pirzkall","sequence":"additional","affiliation":[{"name":"Genentech Inc, South San Francisco, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hina","family":"Patel","sequence":"additional","affiliation":[{"name":"Genentech Inc, South San Francisco, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol","family":"O\u2019Hear","sequence":"additional","affiliation":[{"name":"Genentech Inc, South San Francisco, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Ferrara","sequence":"additional","affiliation":[{"name":"Genentech Inc, South San Francisco, California"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"1","key":"ebr180022r1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.immuni.2013.07.012","article-title":"Oncology meets immunology: the cancer-immunity cycle.","volume":"39","author":"Chen","year":"2013","journal-title":"Immunity"},{"issue":"18","key":"ebr180022r2","doi-asserted-by":"publisher","first-page":"2092","DOI":"10.1200\/JCO.2014.60.0379","article-title":"Toxicities of immunotherapy for the practitioner.","volume":"33","author":"Weber","year":"2015","journal-title":"J Clin Oncol"},{"issue":"1","key":"ebr180022r3","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/s00417-017-3835-2","article-title":"Checkpoint inhibitor-induced uveitis: a case series.","volume":"256","author":"Conrady","year":"2018","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"5","key":"ebr180022r4","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1001\/jamaophthalmol.2018.0920","article-title":"Uveal effusion after immune checkpoint inhibitor therapy.","volume":"136","author":"Thomas","year":"2018","journal-title":"JAMA Ophthalmol"},{"issue":"4","key":"ebr180022r5","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1080\/14737140.2017.1296765","article-title":"Immune-related ocular toxicities in solid tumor patients treated with immune checkpoint inhibitors: a systematic review.","volume":"17","author":"Abdel-Rahman","year":"2017","journal-title":"Expert Rev Anticancer Ther"},{"issue":"4","key":"ebr180022r6","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/0002-9394(75)90387-6","article-title":"Acute macular neuroretinopathy.","volume":"80","author":"Bos","year":"1975","journal-title":"Am J Ophthalmol"},{"issue":"8","key":"ebr180022r7","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1097\/IAE.0b013e318263d0c3","article-title":"Acute macular neuroretinopathy: long-term insights revealed by multimodal imaging.","volume":"32","author":"Fawzi","year":"2012","journal-title":"Retina"},{"issue":"24","key":"ebr180022r8","doi-asserted-by":"publisher","first-page":"5427","DOI":"10.1158\/1078-0432.CCR-15-0420","article-title":"Molecular pathways: targeting IDO1 and other tryptophan dioxygenases for cancer immunotherapy.","volume":"21","author":"Zhai","year":"2015","journal-title":"Clin Cancer Res"},{"issue":"3","key":"ebr180022r9","doi-asserted-by":"publisher","first-page":"e46","DOI":"10.5301\/ejo.5000724","article-title":"A case of bilateral uveitis and papillitis in a patient treated with pembrolizumab.","volume":"26","author":"Abu Samra","year":"2016","journal-title":"Eur J Ophthalmol"},{"issue":"1","key":"ebr180022r10","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s40425-014-0041-1","article-title":"Retinal vasculitis and ocular vitreous metastasis following complete response to PD-1 inhibition in a patient with metastatic cutaneous melanoma.","volume":"2","author":"Manusow","year":"2014","journal-title":"J Immunother Cancer"},{"issue":"4","key":"ebr180022r12","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.amjmed.2012.09.014","article-title":"The clinical utility of a positive antinuclear antibody test result.","volume":"126","author":"Abeles","year":"2013","journal-title":"Am J Med"},{"key":"ebr180022r11","unstructured":"Texcentriq [package insert]. South San Francisco, CA: Genentech, Inc; 2016."}],"container-title":["JAMA Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaophthalmology\/fullarticle\/2712694","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,10]],"date-time":"2019-01-10T11:05:21Z","timestamp":1547118321000},"score":1,"resource":{"primary":{"URL":"http:\/\/archopht.jamanetwork.com\/article.aspx?doi=10.1001\/jamaophthalmol.2018.5191"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,1]]},"references-count":12,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaophthalmol.2018.5191","relation":{},"ISSN":["2168-6165"],"issn-type":[{"value":"2168-6165","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1,1]]}}}